Hydroxyethyl Starch (HES) Solutions

Mortality and Renal Injury Requiring Renal Replacement Therapy

  • In critically ill adult patients, including patients with sepsis, use of hydroxyethyl starch (HES) products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, increases risk of
    • Mortality
    • Renal replacement therapy
  • Do not use HES products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in critically ill adult patients, including patients with sepsis.

Patient counseling

Package inserts

Hydroxyethyl Starch

Updated: January 2018